KEYBANK NATIONAL ASSOCIATION/OH
BankPosition in TAK — Takeda Pharmaceutical Co Ltd
CIK 1089877
BROOKLYN, OH
Position in TAK
as of Jun 30, 2026
· filed Jul 28, 2026
Position Value
$446,980
-$279,280 QoQ
Shares Held
27,884
-28.9% QoQ
Ownership
0.001%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#145
of 375 holders
Holding Since
Dec 2023
6 quarters on record
Voting authority
Sole 1%
Shared 0%
None 99%
Common Shares in TAK Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - Specialty & Generic
Healthcare · as of Jun 30, 2026KEYBANK NATIONAL ASSOCIATION/OH holds $18,715,844 across 8 Drug Manufacturers - Specialty & Generic names. TAK ranks #7 (2.4% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | PAHC |
Phibro Animal Health Corp
|
162,737 | $5,109,941 | |
| 2 | ZTS |
Zoetis Inc.
|
68,691 | $4,936,134 | |
| 3 | VTRS |
Viatris Inc
|
214,241 | $3,402,146 | |
| 4 | HLN |
Haleon plc
|
214,267 | $1,999,111 | |
| 5 | LNTH |
Lantheus Holdings, Inc.
|
16,258 | $1,803,662 | |
| 6 | TEVA |
Teva Pharmaceutical Industries Ltd
|
20,532 | $695,623 | |
| 7 | TAK |
Takeda Pharmaceutical Co Ltd
This page
|
27,884 | $446,980 | |
| 8 | NBIX |
Neurocrine Biosciences Inc
|
1,912 | $322,247 |
All Filings in TAK
Export CSV
6 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $446,980 | 27,884 | Shares | Defined | 2026-07-28 | |
| 2026-03-31 | $726,260 | 39,215 | Shares | Defined | 2026-04-24 | |
| 2025-12-31 | $200,268 | 12,846 | Shares | Defined | 2026-01-30 | |
| 2025-06-30 | $206,792 | 13,376 | Shares | Defined | 2025-08-04 | |
| 2025-03-31 | $175,064 | 11,773 | Shares | Defined | 2025-04-28 | |
| 2023-12-31 | $155,057 | 10,866 | Shares | Defined | 2024-02-13 | |
| No filing history on record for this holder in this stock. | ||||||